Quadrature Capital’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$289K Sell
31,058
-6,728
-18% -$92.6K ﹤0.01% 1618
2026
Q2
$581K Buy
37,786
+34,823
+1,175% +$430K 0.01% 965
2026
Q1
$32.9K Buy
+2,963
New +$26.5K ﹤0.01% 1300
2025
Q2
– Sell
-4,454
Closed -$48.1K – 1246
2025
Q1
$48.1K Buy
+4,454
New +$48.1K ﹤0.01% 980

Other funds holding IMUX

Quadrature Capital's IMUX Position: Q3 2026 in Review

Quadrature Capital reduced its Immunic (IMUX) stake by 18% in Q3 2026, selling an estimated $92.6K and leaving 31,058 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

Quadrature Capital first reported a position in IMUX in Q1 2025 and has held it in 4 quarters since. The position peaked at $581K in Q2 2026. 78 funds tracked by Wall St. Rank hold IMUX as of Q3 2026.

  • Quadrature Capital held 31,058 shares of Immunic worth $289K as of Q3 2026.
  • Quadrature Capital sold 6,728 Immunic shares in Q3 2026, an estimated $92.6K.
  • Immunic made up ﹤0.01% of Quadrature Capital's portfolio in Q3 2026, its #1618 holding.
  • Quadrature Capital first reported a position in Immunic in Q1 2025 and has held it in 4 quarters since.
  • Quadrature Capital's Immunic position peaked at $581K in Q2 2026.
  • 78 funds tracked by Wall St. Rank held Immunic as of Q3 2026.

Based on Quadrature Capital's 13F filing for Q3 2026, filed 13 Nov 2026.